Erythromycin Topical Gel USP recall: Impurity Out of Spec
Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.
Why was Erythromycin Topical Gel USP recalled?
Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 15724, Exp. 06/2022
- Product
- Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.
- Recalling firm
- Teligent Pharma, Inc.
- Quantity
- 11040 tubes
- Distribution
- Nationwide in the USA.
- Recall date
- February 23, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)